Key Objective
Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. 1,080 per equity share ("Offer Price") aggregating to Rs. 4326.36 crores, comprising an offer for sale of 3,705,443 equity shares aggregating to Rs. 400.18 crores by Ramesh Juneja, 3,505,149 equity shares aggregating to Rs. 378.56 crores by Rajeev Juneja, 2,804,119 equity shares aggregating to Rs. 302.85 crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), 17,405,559 equity shares aggregating to Rs. 1879.80 crores by Cairnhill Cipef Limited, 2,623,863 equity shares aggregating to Rs. 283.38 crores by Cairnhill CGPE Limited, 9,964,711 equity shares aggregating to Rs. 1076.19 crores by Beige Limited and 50,000 equity shares aggregating to Rs. 5.40 crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute 10% of the post-offer paid-up equity share capital of the company.